Improving HPV vaccination for childhood cancer survivors
Official title: P30 Administrative Supplement for Multi-Channel Communication Campaigns for Improvements in Cancer Education and Outcomes (MICEO) in Underserved Populations
Funded at St. Jude Children's Research Hospital · NIH-11142247 · Data updated 2026-11-12
This study is all about helping childhood cancer survivors get the HPV vaccine they need to stay healthy, using friendly messages and support from peers to make it easier for them and their families.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | St. Jude Children's Research Hospital NIH-funded |
| Lab location | 1 site (Memphis, United States) |
| Project start | September 1, 2024 |
| Project end | August 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $199,698 |
| NIH project number | 3P30CA021765-45S3 |
| Project ID | NIH-11142247 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are childhood cancer survivors aged 9 to 30 years who are at risk for HPV-related health issues.
✕Less likely to help
Patients who are not childhood cancer survivors or those outside the age range of 9 to 30 years may not benefit from this research.
What this research studies
This research focuses on enhancing HPV vaccination rates among childhood cancer survivors, who are often underserved and at higher risk for developing second cancers due to HPV. The St. Jude Comprehensive Cancer Center will implement and evaluate the Survivor Proud communication campaign, which aims to improve health literacy and vaccination coverage through culturally targeted messaging and peer support. The project will involve continuous quality improvement efforts to ensure the campaign's effectiveness and sustainability, as well as training for clinicians and support for patient families.
Why it matters
Potential benefit: If successful, this research could significantly increase HPV vaccination rates among childhood cancer survivors, reducing their risk of developing HPV-related cancers later in life.
How similar studies have gone: Previous research has shown success in using targeted communication campaigns to improve vaccination rates in underserved populations, making this approach promising.
Where this research is happening
-
St. Jude Children's Research Hospital
Memphis, United States Active
Researchers
- Principal investigator: Roberts, Charles — St. Jude Children's Research Hospital
- Study coordinator: Roberts, Charles
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.